Tapemark Competitors and Similar CompaniesClear all

Catalent's competitors and similar companies include WuXi Biologics.
Catalent
Catalent
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
WuXi Biologics
WuXi Biologics
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
Founding Date
Founding Date
2007
Founding Date
2010
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Bridgewater, US HQ
Buenos Aires, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Locations
Wuxi, CN HQ
George Town, KY
Wuppertal, DE
Hong Kong, HK
Dundalk, IE
Cranbury, US
King Of Prussia, US
Employees
Employees
12,6955% increase
Employees
12,575

Financial

Revenue (est.)
Revenue (est.)
$4.4b (FY, 2024)
Revenue (est.)
¥21.8b (FY, 2025)
Cost of goods
Cost of goods
$3.4b (FY, 2024)
Cost of goods
¥10b (FY, 2025)
Gross profit
Gross profit
$953m (FY, 2024)
Gross profit
¥12b (FY, 2025)
Net income
Net income
($1b) (FY, 2024)
Net income
¥5.7b (FY, 2025)

Operating

Backlog
Backlog
$2.5b (FY, 2023)
Backlog
$18.5b (H1, 2022)
For sources of this data, please see the company profile

View Company Profiles

WuXi Biologics
HQ
Wuxi, CN
Employees
12,575

WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.

View company